Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study

Study identifier:D7000C00004

ClinicalTrials.gov identifier:NCT05872958

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Randomized, Safety and Pharmacokinetics Study of AZD3152 in Healthy Adults (Little DIPPER)

Medical condition

COVID-19

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD3152

Sex

All

Actual Enrollment

98

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 19 May 2023
Primary Completion Date: 20 Aug 2024
Study Completion Date: 20 Aug 2024

Study design

Allocation: Randomized
Endpoint Classification: -
Intervention Model: Parallel Assignment
Masking: -
Primary Purpose: Other

Verification:

Verified 01 Aug 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria